H.R. 7473 · 117th Congress · House

Generic Substitution Noninterference Act

Active· Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Introduced
Apr 7, 22
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Generic Substitution Noninterference Act

This bill prohibits drug manufacturers from helping or directing health care providers to limit prescriptions to brand-name drugs when generic versions are available. The Federal Trade Commission and states may enforce this bill through civil actions.

Action Timeline

4
  1. NOV 01, 2022•Committee

    Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.

  2. APR 07, 2022•IntroReferral

    Introduced in House

  3. APR 07, 2022•IntroReferral

    Introduced in House

  4. APR 07, 2022•IntroReferral

    Referred to the House Committee on the Judiciary.

Committees

2

Administrative State, Regulatory Reform, and Antitrust Subcommittee

hsju05

Referred: Nov 1, 2022

Active

Judiciary Committee

hsju00

Referred: Apr 7, 2022

Active